大剂量抗栓酶3号治疗急性心肌梗塞的临床观察

• 作 者: 陈占先 李新华
• 机 构: 吉林省电力医院,首钢吉林柴油机厂医院,
• 出 处: 水电医学杂志
• 发表日期: 1995年05期
• 关键词: 急性心肌梗塞 尿激酶 蝮蛇抗栓酶 溶栓疗法 再灌注 临床观察 泵衰竭 链激酶 梗塞面积 心源性休克

大剂量精制蝮蛇抗栓酶3号治疗急性心肌梗塞(AMI)46例,与尿激酶(UK)常规治疗 AMI 28例进行临床对比观察。结果表明:抗栓酶3号组24小时仍有再灌注病例,12小时后仍有缩小心梗面积的作用。它对急性心肌梗塞溶栓可靠,且副作用少。

46 cases of acute myocardial infarction (AMI) treated with high dose of viper antithrombin 3 and 28 cases of AMI routinely treated with urokinase (UK) were observed clinically. The results showed that there were still cases of reperfusion in antithrombin No.3 group at 24 hours, and the effect of reducing myocardial infarction area still existed after 12 hours. It is reliable for thrombolysis in acute myocardial infarction with few side effects.